Latest News
Labcorp Holdings Inc.
- Labcorp declares quarterly dividend of $0.72 per share By Investing.com
- Myriad Genetics to sell off Prenatal Health testing business to Labcorp
- Labcorp to buy medical diagnostics company, proprietary prostate cancer test in $872M deal
- Labcorp to Acquire Key BioReference Health Assets in $722M Deal
- Labcorp to buy select assets from Opko Health unit for up to $872 million
- Labcorp to buy BioReference assets for up to $872M
- Labcorp and Thrive Global Launch Direct-to-Consumer Cardiometabolic Test
- Labcorp to report Q3 2026 results Oct. 28, will webcast earnings at 9:00 a.m. ET
- Is This the Right Time to Add Labcorp Stock to Your Portfolio?
- Labcorp pays $2.3 mn over AMCA breach affecting 10.2 mn patients
- A breach at Labcorp’s third-party debt collector exposed personal information tied to more than 27.5 mill
- Attorney General Phil Weiser announces $2.3M national settlement with Labcorp over data breach
Headlines from the last 30 days, linking to the original publishers. See all market news →